Cardea Biomedical Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 296.13%
(FY 2015)
- Profit -169.70%
(FY 2015)
- Ebitda -1068.59%
(FY 2015)
- Net Worth -9.39%
(FY 2015)
- Total Assets -70.08%
(FY 2015)
About Cardea Biomedical Technologies
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhinav and Shashi Gupta serve as directors at the Company.
- CIN/LLPIN
U24239DL2008PTC174891
- Company No.
174891
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cardea Biomedical Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav  | Director | 04-Mar-2008 | Current |
| Shashi Gupta | Director | 15-Nov-2009 | Current |
Financial Performance of Cardea Biomedical Technologies.
Cardea Biomedical Technologies Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 296.13% increase. The company also saw a substantial fall in profitability, with a 169.7% decrease in profit. The company's net worth dipped by a decrease of 9.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cardea Biomedical Technologies?
In 2017, Cardea Biomedical Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cardea Biomedical Technologies?
Unlock and access historical data on people associated with Cardea Biomedical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cardea Biomedical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardea Biomedical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
